As of 2025-07-19, the Relative Valuation of Madrigal Pharmaceuticals Inc (MDGL) is (426.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 334.13 USD, the upside of Madrigal Pharmaceuticals Inc based on Relative Valuation is -227.8%.
The range of the Relative Valuation is (416.28) - (470.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 26.7x | 25.2x |
| Forward P/E multiples | 18.1x - 28.4x | 23.2x |
| Fair Price | (416.28) - (470.97) | (426.87) |
| Upside | -224.6% - -241.0% | -227.8% |
| Date | P/E |
| 2025-07-18 | -18.94 |
| 2025-07-17 | -19.77 |
| 2025-07-16 | -19.56 |
| 2025-07-15 | -17.64 |
| 2025-07-14 | -18.13 |
| 2025-07-11 | -17.88 |
| 2025-07-10 | -17.84 |
| 2025-07-09 | -17.49 |
| 2025-07-08 | -16.30 |
| 2025-07-07 | -16.39 |
| 2025-07-03 | -16.94 |
| 2025-07-02 | -17.02 |
| 2025-07-01 | -17.02 |
| 2025-06-30 | -17.16 |
| 2025-06-27 | -17.05 |
| 2025-06-26 | -16.98 |
| 2025-06-25 | -15.74 |
| 2025-06-24 | -16.16 |
| 2025-06-23 | -16.04 |
| 2025-06-20 | -16.20 |
| 2025-06-18 | -16.03 |
| 2025-06-17 | -15.85 |
| 2025-06-16 | -16.16 |
| 2025-06-13 | -16.76 |
| 2025-06-12 | -16.85 |
| 2025-06-11 | -16.69 |
| 2025-06-10 | -16.01 |
| 2025-06-09 | -15.89 |
| 2025-06-06 | -15.77 |
| 2025-06-05 | -15.54 |
| 2025-06-04 | -15.84 |
| 2025-06-03 | -16.12 |
| 2025-06-02 | -15.46 |
| 2025-05-30 | -15.61 |
| 2025-05-29 | -15.30 |
| 2025-05-28 | -15.36 |
| 2025-05-27 | -15.40 |
| 2025-05-23 | -15.17 |
| 2025-05-22 | -15.50 |
| 2025-05-21 | -15.72 |
| 2025-05-20 | -16.60 |
| 2025-05-19 | -16.48 |
| 2025-05-16 | -16.50 |
| 2025-05-15 | -16.54 |
| 2025-05-14 | -16.04 |
| 2025-05-13 | -16.74 |
| 2025-05-12 | -17.05 |
| 2025-05-09 | -16.70 |
| 2025-05-08 | -16.98 |
| 2025-05-07 | -16.94 |